Cookies on Paperstars

We use Google Analytics to understand how people use Paperstars and improve the site. Are you okay with that?

Single-pill combination of indapamide and perindopril: potential of practical application

Kochergina A. Kashtalap V (2024). Single-pill combination of indapamide and perindopril: potential of practical application. Russian Journal of Cardiology, 29(3), 5831. https://doi.org/10.15829/1560-4071-2024-5831

Overall rating
(5.0) 1 review
Authors
A. M. Kochergina, V. V. Kashtalap
Journal
Russian Journal of Cardiology
First published
2024
Number of citations
1
Type
Journal Article

Abstract

The effectiveness of blood pressure control can be increased with the use of single-pill combinations. When choosing an agent, the evidence of its components should be focused. The selection criteria are not only the direct effects of reducing blood pressure, but also organ protection and the impact on prognosis. Perindopril and indapamide have many years of experience in use in a wide range of patients and are used with the same effectiveness in the treatment of hypertension in young and elder­ly patients, in normal-weight and obese people, as tools for the primary prevention of myocardial infarction and stroke, and also as a way to prevent recurrent events.The article provides data on the advantages of perindopril and indapamide, the potential of its single-pill combination, the pleiotropic and organ protective properties of this drug. We systematized results of related studies and reflected the main conclusions. Attention is paid to the latest data on the long-term effect of indapamide therapy on the risk of cardiovascular events.

Embed Review

Share a live Paperstars badge for Single-pill combination of indapamide and perindopril: potential of practical application. Copy the HTML below and paste it into your site.

Paperstars badge preview

Reviews

Informative Title

100%
Appropriate
Slightly Misleading
Exaggerated

Methods

100%
Sound
Questionable
Inadequate

Statistical Analysis

100%
Appropriate
Some Issues
Major concerns

Data Presentation

100%
Complete and Transparent
Minor Omissions
Misrepresented

Discussion

100%
Appropriate
Slightly Misleading
Exaggerated

Limitations

100%
Appropriately acknowledged
Minor Omissions
Inadequate

Data Available

100%
Completely Available
Partial data available
Not Open Access

Sign in to add a review. Help the research community by sharing your assessment of this journal-article.

MagentaCytoplasm Oct 07, 2026

This is a narrative review / expert opinion on the single-pill combination of indapamide and perindopril. Assessed within its genre, the title is appropriate and non-misleading; the data are logically structured, with key trials presented consistently; the discussion is clinically oriented and supports the role of the combination in hypertension management. As a reader, I found the paper useful: it answers practical clinical questions and summarises the evidence in an accessible way. Scientifically, the paper has limitations: no formal literature search strategy, no dedicated «Limitations» section, and no quantitative synthesis. This is typical for a narrative review but reduces methodological rigour. Sponsorship by the manufacturer should also be considered. Nevertheless, within its stated genre, the article achieves its goal of informing clinicians. Therefore, I rate it «5 stars» based on its high practical value and clear presentation.